tm logo

Monitor this mark

View On USPTO

DIFFUSIO2N
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 29 Jul 2022

Last Applicant/ Owned by

Diffusion Pharmaceuticals LLC

1317 Carlton Avenue, Suite 200

Charlottesville

VA

22902

Serial Number

77577940 filed on 24th Sep 2008

Registration Number

4088239 registered on 17th Jan 2012

in the Principal Register

Correspondent Address

Michael Tsimaras

Michael Tsimaras

Suite 203

75 Main St

Millburn NJ 07041

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

DIFFUSIO2N

Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals

First Use Date in General

31st Oct 2011

First Use Date in Commerce

31st Oct 2011

Mark Details

Serial Number

No 77577940

Mark Type

No Service/Collective Mark

Attorney Docket Number

No DFN-13-TM-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Jul 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
17th Jan 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
17th Jan 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
17th Jan 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
17th Jan 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Dec 2017TEAS SECTION 8 & 15 RECEIVED
15th Dec 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15th Dec 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17th Jan 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17th Jan 2012REGISTERED-PRINCIPAL REGISTER